The 7 most recent market catalysts affecting $SIBN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Maintains Buy on SI-BONE, Raises Price Target to $25
UBS analyst Patrick Wood maintained a 'Buy' rating on SI-BONE and raised the price target from $24 to $25. This action signals continued bullish sentiment from a prominent investme…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Securities Reiterates Buy on SI-BONE, Raises Price Target to $23
Truist Securities analyst Richard Newitter reiterated a 'Buy' rating on SI-BONE (SIBN) and raised the price target from $21 to $23. This action signals continued confidence in the …
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Buy on SI-BONE, Raises Price Target to $20
TD Cowen analyst Mathew Blackman maintained a 'Buy' rating on SI-BONE and raised the price target from $18 to $20. This action signals increased confidence from a prominent analyst…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 75
SI-BONE Raises FY2026 Sales Guidance from $230.000M-$233.000M to $231.000M-$233.000M vs $231.775M Est
SI-BONE (SIBN) has updated its FY2026 sales guidance, raising the lower bound of its previous range from $230 million to $231 million, while keeping the upper bound at $233 million…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 92
SI-BONE Q2 EPS $(0.09) Beats $(0.15) Estimate, Sales $56.010M Beat $55.335M Estimate
SI-BONE (SIBN) announced its Q2 financial results, reporting a loss of $(0.09) per share, which significantly beat the analyst estimate of $(0.15). Additionally, the company's sale…
Jul 28, 2026
Corporate Catalyst
Neutral
Impact 65
UBS Initiates Coverage On SI-BONE with Buy Rating, Announces Price Target of $24
UBS analyst Patrick Wood initiated coverage on SI-BONE (SIBN) with a 'Buy' rating and set a price target of $24. This is a positive development for SI-BONE as new analyst coverage,…
Jul 16, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Securities Maintains Buy on SI-BONE, Raises Price Target to $21
Truist Securities analyst Richard Newitter has maintained a 'Buy' rating on SI-BONE (SIBN) and raised the price target from $18 to $21. This action signals increased confidence fro…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.